Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression

Biological Psychiatry

Volumn 50, Issue 5, 2001, Pages 313-322

  Parsey, Ramin V ^a,b   Oquendo, Maria A ^a   Zea Ponce, Yolanda ^a   Rodenhiser, Janine ^a   Kegeles, Lawrence S ^a   Pratap, Mali ^a   Cooper, Thomas B ^b   Van Heertum, Ronald ^a   Mann, J John ^a   Laruelle, Marc ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Amphetamine; D2 receptors; Depression; Dopamine; SPECT

Indexed keywords

AMPHETAMINE; DOPAMINE 2 RECEPTOR; IODINE 123; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 6 METHOXYSALICYLAMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DOPAMINE RELEASE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PARTITION COEFFICIENT; PRIORITY JOURNAL; RECEPTOR DENSITY; REDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AMPHETAMINE; BENZAMIDES; CORPUS STRIATUM; DEPRESSIVE DISORDER, MAJOR; DOPAMINE; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PYRROLIDINES; RECEPTORS, DOPAMINE D2; SYNAPTIC TRANSMISSION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0035450546     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01089-7     Document Type: Article

References (51)

1. Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort
2. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
3. Unchanged density of caudate nucleus dopamine uptake sites in depressed suicide victims
4. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients
5. Negative symptoms in schizophrenia. Definition and reliability
6. Dopamine D2 receptor density and personal detachment in healthy subjects
7. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
8. Dopamine and depression
9. Comparison of bolus and infusion methods for receptor quantitation: Application to [18F]cyclofoxy and positron emission tomography
10. Dopamine D2 receptors in depression measured with single photon emission computed tomography
11. Prefrontal cortical dopamine depletion enhances the responsiveness of the mesolimbic dopamine neurons to stress
12. The role of dopamine in mood disorders
13. Dopamine and depression-striatal dopamine D2 receptor SPECT before and after antidepressant therapy
14. D2 dopamine receptors and personality traits
15. A rating scale for depression
16. Striatal D2 dopamine receptor binding charactereristics in vivo in patients with alcohol dependence
17. Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress
18. Role of the dopaminergic system in depression
19. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia
20. Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans
21. Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT
22. Dopamine D-2 receptor imaging radiopharmaceuticals: Synthesis, radiolabeling, and in vitro binding of R-(+)- and S-(-)-3-iodo-2-hydroxy-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl] benzamide
23. Striatal dopamine transporter density in major depression
24. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review
25. Increased dopamine transmission in schizophrenia: Relationship to illness phases
26. SPECT imaging of striatal dopamine release after amphetamine challenge
27. Single photon emission computerized tomography imaging of amphetamine-induce dopamine release in drug free schizophrenic subjects
28. Imaging D-2 receptor occupancy by endogenous dopamine in humans
29. Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates
30. Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects
31. 2 receptors in healthy subjects
32. 3H]raclopride
33. Reduced amphetamine-stimulated dopamine release in cocaine addicts as measured by [123I]IBZM SPECT
34. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography
35. From motivation to action: Functional interface between the limbic system and the motor system
36. The brief psychiatric rating scale
37. Mania, depression and brain dopamine
38. Low dopamine D(2) receptor binding potential in social phobia
39. Reward processing in primate orbitofrontal cortex and basal ganglia
40. 2 receptors in human subjects with iodine-123-IBZM
41. Clinical and psychometric correlates of dopamine D2 binding in depression
42. The Structured Clinical interview for DSM-III-R: 1. History, rationale and description
43. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons
44. Prediction of imipramine antidepressant response by a one-day dextro-amphetamine trial
45. Imaging studies of cocaine in the human brain and studies of the cocaine addict
46. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
47. Dopaminergic mechanism in depression and mania
48. Chronic mild stress-induced anhedonia: A realistic animal model of depression
49. Brain dopamine and reward
50. Rapid automated algorithm for aligning and reslicing PET images
51. 123I]IBZM: A reliable procedure for routine clinical studies